Alibaba has agreed to pay $600 million to resolve a US investigation into drug sales on its platform. This was reported by Qazaqyia.kz citing Reuters.
The probe concerned the sale of drugs on Alibaba's platform. The company agreed to pay the fine to settle the matter.